Office of the Governor | ICYMI: BeiGene Breaks Ground on New Manufacturing and Clinical R&D Center at the Princeton West Innovation Campus in New Jersey

Flagship U.S. Facility Will Embrace Biologic Manufacturing and Late Stage Analysis and Medical Improvement of Revolutionary Most cancers Medicines 

Sixth U.S. Location Provides to World Growth and Brings New Jobs to New Jersey 

Hopewell, N.J., CAMBRIDGE, Mass., BASEL, Switzerland and BEIJING – April 29, 2022 — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a worldwide biotechnology firm centered on growing progressive and reasonably priced medicines to enhance therapy outcomes and entry for sufferers worldwide, at present introduced the groundbreaking of its flagship U.S. manufacturing and scientific R&D heart on the Princeton West Innovation Campus in Hopewell, N.J. 

“Our deliberate flagship U.S. R&D and manufacturing heart helps our dedication to combat for all times for folks dwelling with most cancers around the globe, by state-of-the-art commercial-stage biologic pharmaceutical manufacturing, late-stage analysis and scientific improvement capabilities,” mentioned John Oyler, Co-Founder, Chairman and CEO of BeiGene. “The Princeton-Hopewell space is a superb location for BeiGene and the thriving life science neighborhood, with a deep expertise pool as we proceed to advance our pipeline of progressive most cancers medicines and work to diversify our world provide chain.” 

The preliminary section of building is predicted to incorporate roughly 400,000 sq. ft of devoted commercial-stage biologic pharmaceutical manufacturing area, with capability for as much as 16,000 liters of biologics system. Development of the preliminary section is predicted to run by 2024.  BeiGene intends to recruit a whole bunch of recent hires from the world’s enticing expertise market to assist its continued development and its dedication to producing life-saving oncology medicines.

“BeiGene’s plans for a whole bunch of recent jobs in New Jersey converse to our efforts to develop our state’s business-friendly surroundings and to our dedication to fostering innovation,” mentioned Governor Phil Murphy. “We’re proud to welcome BeiGene to the Princeton space and look ahead to the corporate manufacturing progressive most cancers medicines in its new state-of-the-art facility.”

In November 2021, BeiGene acquired the Hopewell property from Lincoln Equities Group and has retained DPR Development as its building administration agency and IPS as its architectural and engineering agency. The property has multiple million sq. ft of developable actual property for future potential enlargement. 

Added Oyler: “At BeiGene, we’re dedicated to not solely delivering progressive and reasonably priced medicines but additionally to upholding the best requirements of ethics and integrity, operational excellence, and environmental stewardship. This dedication applies to the whole lot we do, together with the event of BeiGene’s Hopewell undertaking.” 

“As a pacesetter with an extended historical past in New Jersey’s biotech business, Hopewell Township welcomes BeiGene to our neighborhood,” mentioned Hopewell Mayor Courtney Peters-Manning  “We’re happy that BeiGene will convey their state-of-the-art applied sciences, manufacturing, and R&D heart to Hopewell, whose merchandise will assist numerous folks everywhere in the world. We look ahead to persevering with to work with BeiGene and are enthusiastic about what can be produced right here in Hopewell.”

BeiGene presently has 5 places of work within the U.S., in San Mateo and Emeryville, Calif., Cambridge, Mass., Ridgefield Park, N.J. and Fulton, Md. Globally, the corporate has greater than 30 places of work throughout 5 continents.